Cornell’s Universal CAR-T Therapy for Feline Lymphoma

The headline

Cornell is developing an off-the-shelf CAR-T therapy for cats with lymphoma.

The science, explained

CAR-T therapy reprograms immune cells to recognize and attack cancer. Conventional CAR-T treatment is built from each patient’s own cells, which makes production slow and expensive. Cornell’s project instead aims to create a ready-made source of feline T-cells using artificial thymic organoids.

What it means for your cat

• The treatment is still a research project, not an option available through veterinary clinics today.
• The work focuses on lymphoma, one of the most common cancers diagnosed in cats.
• Cat parents facing a current diagnosis should discuss established treatments and recruiting clinical trials with a veterinary oncologist.

Editorial note: Cat Cancer News summarizes research for general information. It is not veterinary advice. Always discuss diagnosis and treatment with a licensed veterinarian.